Correlation Between Oncopeptides and SolTech Energy

Can any of the company-specific risk be diversified away by investing in both Oncopeptides and SolTech Energy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and SolTech Energy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncopeptides AB and SolTech Energy Sweden, you can compare the effects of market volatilities on Oncopeptides and SolTech Energy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of SolTech Energy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and SolTech Energy.

Diversification Opportunities for Oncopeptides and SolTech Energy

0.7

Correlation Coefficient

Oncopeptides  SolTech Energy

Poor diversification

The 3 months correlation between Oncopeptides and SolTech is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and SolTech Energy Sweden in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SolTech Energy Sweden and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with SolTech Energy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SolTech Energy Sweden has no effect on the direction of Oncopeptides i.e., Oncopeptides and SolTech Energy go up and down completely randomly.

Pair Corralation between Oncopeptides and SolTech Energy

Assuming the 90 days trading horizon Oncopeptides AB is expected to generate 0.96 times more return on investment than SolTech Energy. However, Oncopeptides AB is 1.04 times less risky than SolTech Energy. It trades about -0.08 of its potential returns per unit of risk. SolTech Energy Sweden is currently generating about -0.12 per unit of risk. If you would invest  216.00  in Oncopeptides AB on September 2, 2024 and sell it today you would lose (51.00) from holding Oncopeptides AB or give up 23.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Oncopeptides AB  vs.  SolTech Energy Sweden

Oncopeptides AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

SolTech Energy Sweden

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SolTech Energy Sweden has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Oncopeptides and SolTech Energy

The main advantage of trading using opposite Oncopeptides and SolTech Energy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, SolTech Energy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SolTech Energy will offset losses from the drop in SolTech Energy's long position.

The idea behind Oncopeptides AB and SolTech Energy Sweden pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.